ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition states.

Autor: Verstappe J; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Skrypek N; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., De Coninck J; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; VIB Single Cell Core, VIB, Ghent-Leuven, Belgium., Soen B; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Taminau J; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Tatari M; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Bruneel K; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Loret N; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., De Clercq K; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Van den Broecke C; Department of Pathology, Ghent Unviversity Hospital, Ghent, Belgium.; AZ Sint-Lucas Gent, Ghent, Belgium., Van De Vijver K; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, Ghent Unviversity Hospital, Ghent, Belgium.; Department of Pathology, Antwerp University Hospital, Antwerp, Belgium., Van Dorpe J; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Pathology, Ghent Unviversity Hospital, Ghent, Belgium., Haigh J; Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.; Paul Albrechtsen Research Institute, CancerCare Manitoba, Winnipeg, MB, Canada., De Craene B; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Goossens S; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium., Vandamme N; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; VIB Single Cell Core, VIB, Ghent-Leuven, Belgium.; VIB-UGent Center for Inflammation Research, Technologiepark 71, 9052 Ghent, Belgium., Berx G; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.

Publikováno v: IScience [iScience] 2024 Oct 16; Vol. 27 (11), pp. 111169. Date of Electronic Publication: 2024 Oct 16 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tolerance of the porcine pancreas to warm and cold ischemia: comparison between University of Wisconsin and histidine–tryptophan–ketoglutarate solution

Autor: Troisi, R., Meester, D., Regaert, B., van den Broecke, C., Cuvelier, C., Hesse, U.J.

Publikováno v: In Transplantation Proceedings 2002 34(3):820-822

Shallow whole-genome sequencing: a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue-a glioma-driven study.

Autor: Van der Eecken K; Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute (CRIG), Ghent, Belgium., Van der Linden M; Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute (CRIG), Ghent, Belgium.; Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University, Ghent University Hospital, Ghent, Belgium., Raman L; Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.; Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University, Ghent University Hospital, Ghent, Belgium., Creytens D; Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute (CRIG), Ghent, Belgium., Dedeurwaerdere F; Department of Pathology, AZ Delta, Roeselare, Belgium., De Winne K; Department of Pathology, Antwerp University Hospital, Antwerp, Belgium., Ferdinande L; Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute (CRIG), Ghent, Belgium., Lammens M; Department of Pathology, Antwerp University Hospital, Antwerp, Belgium., Menten B; Cancer Research Institute (CRIG), Ghent, Belgium.; Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University, Ghent University Hospital, Ghent, Belgium., Rottiers I; Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute (CRIG), Ghent, Belgium., Van Gaever B; Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium., Van den Broecke C; Department of Pathology, AZ Sint-Lucas, Ghent, Belgium., Van de Vijver K; Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute (CRIG), Ghent, Belgium., Van Roy N; Cancer Research Institute (CRIG), Ghent, Belgium.; Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University, Ghent University Hospital, Ghent, Belgium., Verbeke S; Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute (CRIG), Ghent, Belgium., Van Dorpe J; Department of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium. jo.vandorpe@uzgent.be.; Cancer Research Institute (CRIG), Ghent, Belgium. jo.vandorpe@uzgent.be.

Publikováno v: Virchows Archiv : an international journal of pathology [Virchows Arch] 2022 Mar; Vol. 480 (3), pp. 677-686. Date of Electronic Publication: 2022 Jan 16.

Survival impact of incidental subventricular zone irradiation in IDH-wildtype glioblastoma.

Autor: Hallaert G; Department of Neurosurgery, Ghent University Hospital, Ghent, Belgium., Pinson H; Department of Neurosurgery, Ghent University Hospital, Ghent, Belgium., Van den Broecke C; Department of Pathology, AZ St Lucas Gent, Gent, Belgium.; Department of Pathology, Ghent University Hospital, Ghent, Belgium., Sweldens C; Department of Radiation Oncology, AZ Delta, Roeselare, Belgium., Van Roost D; Department of Neurosurgery, Ghent University Hospital, Ghent, Belgium., Kalala JP; Department of Neurosurgery, Ghent University Hospital, Ghent, Belgium., Boterberg T; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2021 May; Vol. 60 (5), pp. 613-619. Date of Electronic Publication: 2021 Mar 09.